Chase Science Co. Ltd.
Chase Science Co., Ltd. operates as an electronic payment IT solution provider in China. It offers electronic payment-related software and hardware products and services for merchants; and bank network controllers and card printing equipment, and services for banks. The company also offers industry payment solutions and digital intelligent solutions for small, medium, and micro merchants, includi… Read more
Chase Science Co. Ltd. (300941) - Total Liabilities
Latest total liabilities as of June 2025: CN¥71.91 Million CNY
Based on the latest financial reports, Chase Science Co. Ltd. (300941) has total liabilities worth CN¥71.91 Million CNY as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Chase Science Co. Ltd. - Total Liabilities Trend (2019–2024)
This chart illustrates how Chase Science Co. Ltd.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Chase Science Co. Ltd. Competitors by Total Liabilities
The table below lists competitors of Chase Science Co. Ltd. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dexco S.A.
SA:DXCO3
|
Brazil | R$11.03 Billion |
|
BOROSIL RENEWABLES LIMITED
NSE:BORORENEW
|
India | ₹3.70 Billion |
|
Autoneum Holding AG
OTCGREY:ATNNF
|
USA | $1.20 Billion |
|
Hunan Investment Group Co Ltd
SHE:000548
|
China | CN¥395.75 Million |
|
Xinjiang Tianrun Dairy Co Ltd
SHG:600419
|
China | CN¥3.17 Billion |
|
Thyrocare Technologies Limited
NSE:THYROCARE
|
India | ₹1.46 Billion |
|
Tips Music Limited
NSE:TIPSMUSIC
|
India | ₹1.13 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Chase Science Co. Ltd.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 21.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Chase Science Co. Ltd.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Chase Science Co. Ltd. (2019–2024)
The table below shows the annual total liabilities of Chase Science Co. Ltd. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥106.81 Million | -1.64% |
| 2023-12-31 | CN¥108.59 Million | -23.39% |
| 2022-12-31 | CN¥141.74 Million | +15.01% |
| 2021-12-31 | CN¥123.24 Million | -6.93% |
| 2020-12-31 | CN¥132.42 Million | +11.54% |
| 2019-12-31 | CN¥118.72 Million | -- |